A citation-based method for searching scientific literature

Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger, John K Chan, Susan A Davidson, Robert S Mannel, Paul A DiSilvestro, Heather A Lankes, Nilsa C Ramirez, Mary Claire King, Elizabeth M Swisher, Michael J Birrer. JAMA Oncol 2016
Times Cited: 331



Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake, Barbara Norquist, Kathryn P Pennington, Rochelle L Garcia, Mary-Claire King, Elizabeth M Swisher. Proc Natl Acad Sci U S A 2011
Times Cited: 559




List of shared articles



Times cited

The current landscape of molecular profiling in the treatment of epithelial ovarian cancer.
Carolyn E Haunschild, Krishnansu S Tewari. Gynecol Oncol 2021
3

Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.
Huma Q Rana, Lindsay Kipnis, Kristin Hehir, Angel Cronin, Tim Jaung, Samantha M Stokes, Fatemeh Fekrmandi, Donna Vatnick, Ursula A Matulonis, Judy E Garber,[...]. Gynecol Oncol 2021
1

Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations.
Talayeh S Ghezelayagh, Kathryn P Pennington, Barbara M Norquist, Nithisha Khasnavis, Marc R Radke, Mark R Kilgore, Rochelle L Garcia, Ming Lee, Ronit Katz, Kimberly K Leslie,[...]. Gynecol Oncol 2021
0

Inherited predisposition to breast cancer in the Carolina Breast Cancer Study.
Tom Walsh, Suleyman Gulsuner, Ming K Lee, Melissa A Troester, Andrew F Olshan, H Shelton Earp, Charles M Perou, Mary-Claire King. NPJ Breast Cancer 2021
0

Comprehensive Mutational Analysis of the BRCA1-Associated DNA Helicase and Tumor-Suppressor FANCJ/BACH1/BRIP1.
Jennifer A Calvo, Briana Fritchman, Desiree Hernandez, Nicole S Persky, Cory M Johannessen, Federica Piccioni, Brian A Kelch, Sharon B Cantor. Mol Cancer Res 2021
0

Case Report: Detection of a Novel Germline PALB2 Deletion in a Young Woman With Hereditary Breast Cancer: When the Patient's Phenotype History Doesn't Lie.
Carmine De Angelis, Carmela Nardelli, Paola Concolino, Martina Pagliuca, Mario Setaro, Elisa De Paolis, Pietro De Placido, Valeria Forestieri, Giovanni Luca Scaglione, Annalisa Ranieri,[...]. Front Oncol 2021
0

Controversies in Hereditary Cancer Management.
Mariam M AlHilli, Holly J Pederson. Obstet Gynecol 2021
0


Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance.
Rachel M Hurley, Cordelia D McGehee, Ksenija Nesic, Cristina Correia, Taylor M Weiskittel, Rebecca L Kelly, Annapoorna Venkatachalam, Xiaonan Hou, Nicholas M Pathoulas, X Wei Meng,[...]. NAR Cancer 2021
0

Epithelial ovarian cancer risk: A review of the current genetic landscape.
Nicola Flaum, Emma J Crosbie, Richard J Edmondson, Miriam J Smith, Dafydd G Evans. Clin Genet 2020
7

Whole-exome sequencing of ovarian cancer families uncovers putative predisposition genes.
Qianqian Zhu, Jianmin Zhang, Yanmin Chen, Qiang Hu, He Shen, Ruea-Yea Huang, Qian Liu, Jasmine Kaur, Mark Long, Sebastiano Battaglia,[...]. Int J Cancer 2020
6

A systematic review of predicted pathogenic PALB2 variants: an analysis of mutational overlap between epithelial cancers.
Boris Janssen, Sarah Bellis, Thomas Koller, Marc Tischkowitz, Siong-Seng Liau. J Hum Genet 2020
4

Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals.
Di Shao, Shaomin Cheng, Fengming Guo, Changbin Zhu, Yuying Yuan, Kunling Hu, Zhe Wang, Xuan Meng, Xin Jin, Yun Xiong,[...]. Cancer Sci 2020
6

Current Approaches to Germline Cancer Genetic Testing.
Elena M Stoffel, John M Carethers. Annu Rev Med 2020
3

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M Dunning, James Redman, James Scarth, Inga Plaskocinska,[...]. J Clin Oncol 2020
76

Simultaneous germline and somatic sequencing in ovarian carcinoma: mutation rate and impact on clinical decision-making.
Soledad Jorge, Andrew S McFaddin, Kemi M Doll, Kathryn P Pennington, Barbara M Norquist, Robin L Bennett, Colin C Pritchard, Elizabeth M Swisher. Gynecol Oncol 2020
6

Genetic cancer predisposition syndromes among older adults.
Yanin Chavarri-Guerra, Thomas P Slavin, Ossian Longoria-Lozano, Jeffrey N Weitzel. J Geriatr Oncol 2020
0

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
41

Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?
Davide Angeli, Samanta Salvi, Gianluca Tedaldi. Int J Mol Sci 2020
12


Collaborative Group of the Americas on Inherited Gastrointestinal Cancer Position statement on multigene panel testing for patients with colorectal cancer and/or polyposis.
Brandie Heald, Heather Hampel, James Church, Beth Dudley, Michael J Hall, Maureen E Mork, Aparajita Singh, Elena Stoffel, Jessica Stoll, Y Nancy You,[...]. Fam Cancer 2020
6

Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management.
Shijie Wu, Jiaojiao Zhou, Kun Zhang, Huihui Chen, Meng Luo, Yuexin Lu, Yuting Sun, Yiding Chen. Front Oncol 2020
10

Germline PALB2, ATM variants in a patient with breast and ovarian cancer at risk for familial cancer syndrome: Is there a role for risk-reducing salpingo-oophorectomy?
Semiramis L Carbajal-Mamani, Merry J Markham, Joaquín Santolaya-Forgas, Jacqueline C Castagno, Joel Cardenas-Goicoechea. Obstet Gynecol Sci 2020
0

Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes.
Deepak N Subramanian, Magnus Zethoven, Simone McInerny, James A Morgan, Simone M Rowley, Jue Er Amanda Lee, Na Li, Kylie L Gorringe, Paul A James, Ian G Campbell. Nat Commun 2020
4



Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer.
Klara Lhotova, Lenka Stolarova, Petra Zemankova, Michal Vocka, Marketa Janatova, Marianna Borecka, Marta Cerna, Sandra Jelinkova, Jan Kral, Zuzana Volkova,[...]. Cancers (Basel) 2020
4

Population Screening for Inherited Predisposition to Breast and Ovarian Cancer.
Ranjit Manchanda, Sari Lieberman, Faiza Gaba, Amnon Lahad, Ephrat Levy-Lahad. Annu Rev Genomics Hum Genet 2020
9


Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancer.
Stephanie Alimena, Lauren Scarpetti, Erica L Blouch, Linda Rodgers, Kristen Shannon, Marcela Del Carmen, Annekathryn Goodman, Whitfield B Growdon, Eric Eisenhauer, Rachel Clark Sisodia. Int J Gynecol Cancer 2020
1

Emerging drugs for the treatment of ovarian cancer: a focused review of PARP inhibitors.
Elizabeth K Lee, Ursula A Matulonis. Expert Opin Emerg Drugs 2020
1



Inherited mutations in fallopian tube, ovarian and primary peritoneal carcinoma: Changes in diagnoses and mutational frequency over 20 years.
Arielle S Weiss, Elizabeth Swisher, Kathryn P Pennington, Marc Radke, Nithisha Khasnavis, Rochelle L Garcia, Mark R Kilgore, Ming K Lee, Barbara M Norquist. Gynecol Oncol 2020
0